Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients

NCT02106962 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Arteriovenous Fistula

Interventions

DRUG: Topical Tranexamic Acid 5% with bacitracin
OTHER: Topical Tranexamic Acid 25% with bacitracin

Sponsor

California Institute of Renal Research

Collaborators

[object Object]